Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multinational, Multicentre, Randomised, Single-period Parallel Study to Assess the Efficacy, Safety and Utility of Fully Closed-loop Insulin Delivery Compared to Standard Insulin Therapy With CGM in Adults With Type 2 Diabetes

NCT06579404 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.

NCT NCT06579404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06579404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multinational, Multicentre, Randomised, Single-period Parallel Study to Assess the Efficacy, Safety and Utility of Fully Closed-loop Insulin Delivery Compared to Standard Insulin Therapy With CGM in Adults With Type 2 Diabetes
Lead sponsor
University of Cambridge
Phase
Not applicable
Overall status
Recruiting
Start date
December 6, 2024
Completion date
July 31, 2027
Enrollment
224 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes treated with insulin